CORT vs. ETN

In the year-to-date period, CORT achieves a 42.31% return, which is significantly higher than ETN's -12.65% return. Over the past 10 years, CORT has outperformed ETN with an annualized return of 27.83%, while ETN has yielded a comparatively lower 18.69% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Eaton Corporation plc (ETN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current CORT Sharpe Ratio is 1.74, which is higher than the ETN Sharpe Ratio of -0.17. The chart below compares the historical Sharpe Ratios of CORT and ETN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

CORT has not paid dividends to shareholders, while ETN's dividend yield for the trailing twelve months is around 1.34%.

The maximum CORT drawdown since its inception was -94.28%, which is greater than ETN's maximum drawdown of -68.95%. Use the drawdown chart below to compare losses from any high point for CORT and ETN. For additional features, visit the drawdowns tool.

Corcept Therapeutics Incorporated (CORT) has a higher volatility of 81.39% compared to Eaton Corporation plc (ETN) at 19.30%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than ETN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Eaton Corporation plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.